Revolutionary approach
alternative to antibiotics.

Stemtrix Corporation has developed a new highly effective solution an antibacterial drug that is an alternative to antibiotics.

Global crisis: The widespread and uncontrolled use of antibiotics has given rise to the spread of antibiotic-resistant strains

Innovations in the treatment of infectious diseases. Radical reduction in the use of antibiotics in veterinary medicine and medicine

Instead of killing the bacteria, the drugs put them into a vegetative state, blocking their ability to cause disease.

$2trillion

Annual losses from antibiotic resistance of world GDP

10million

Annual population losses from antibiotic resistance

MDR

Diseases caused by multidrug-resistant bacterial pathogens

7years

Antibiotics development time until approval

Innovative methods to antibiotic replacement

Innovative methods to antibiotic replacement

The mission of Stemtrix Corp. is to bring to the market a group of drugs for the treatment of infectious diseases, which will allow: to avoid the development and block the existing mechanisms of resistance; reduce the virulence and size of pathogen populations

The spread of antibiotic-resistant strains

The spread of antibiotic-resistant strains

The widespread and uncontrolled use of antibiotics has given rise to the spread of antibiotic-resistant strains. One of the reasons is the industrial use of antibiotics in the rearing of farm animals, technologically providing for their use to ensure proper productivity.

Why Stemtrix is a revolutionary alternative to antibiotics?

Stemtrix preparations do not kill, but serve as mediators of the transition of their pathogens from an active state to a vegetative one. Stemtrix is a radical reduction in the use of antibacterial drugs and antibiotics. The drugs are intended for the prevention and treatment of intestinal and other inflammatory infections of a bacterial nature.

Component of feeds
The active substances of the drug are natural components of the diets of farm animals and birds used in medicine and food industry

No resistance
The active ingredients of the drug are natural regulators of metabolic processes in the bacterial cell, as a result the bacterial cell has no mechanisms of resistance

Without destruction
The drugs will suppress virulence, pathogenicity of pathogenic bacteria, without resorting to the principle of direct destruction of the bacterium

Immune system
The preparations also include substances that modulate the immune response to the introduction of pathogenic bacteria into the body

Stemtrix products portfolio

Our medications can be used in the tretment of the large number of diseases: gastrointestinal tract, urogenital pathways, skin, ear. Combination therapy is possible, including the use of the drug and any antibacterial agent

Animal Medicine

Rezovet®

Status:

Prevention and treatment of poultry in bacterial diseases

Read More

Animal Medicine

Rezomast®

Status:

Treatment and prevention of mastitis cattle

Read More

Animal Medicine

Rezovet-P®

Status:

Prevention and treatment of animals in bacterial diseases

Read More

Animal Medicine

Endorezor®

Status:

Treatment and prevention of cattle endometrit

Read More

Animal Medicine

Rezohoof®

Status:

Prevention and treatment of animals in diseases of the hoof

Read More

Animal Medicine

Rezoakva®

Status:

Prevention and treatment of fish for bacterial diseases

Read More

Results of production tests

Results of Rezovet®

The obtained results of the study of the use of Rezovet in production conditions give grounds for its use as an effective tool for the prevention and treatment of such bacterial infections as: hemophilosis, colibacillosis, mycoplasmosis, pasteurellosis, pullorosis, necrotic enteritis, salmonellosis and its use in the standard scheme of poultry rearing.

Results of Rezomast®

Rezomast does not contain antibiotics, does not have waiting periods for milk, has a stable and long-lasting therapeutic efficacy, helps to stop inflammatory changes in the breast tissue and reduces the risk of recurrence of the disease. The results of the study of the use of Rezomast in industrial conditions give grounds for its use as an effective tool for the treatment of subclinical and clinical mastitis.